Company announcement no. 33-2023
Today, Audientes ("Audientes" or the "Company"), CVR 36047631, releases its financial results for
Q3, 2023.
Performance highlights for Q3 2023
TDKK | Q3 2023 | Q3 2022 | Q1-Q3 2023 | Q1-Q3 2022 | 2022 |
Revenue | 8 | 2,224 | 1,261 | 3,232 | 79 |
Other operating income | 214 | 214 | 1,180 | 642 | 856 |
EBITDA | -2,246 | -1,804 | -6,580 | -8,490 | -14,026 |
Profit/loss for the period | -3,716 | -3,713 | -11,041 | -12,343 | -24,362 |
Cash and cash equivalents | 342 | 114 | 342 | 114 | 6,948 |
Equity | 4,315 | 13,141 | 4,315 | 13,141 | 13,049 |
Equity ratio (%) | 25.0% | 46.6% | 25.0% | 46.6% | 49.1% |
Earnings per share (DKK) | -0.09 | -0.40 | -0.31 | -1.32 | -1.28 |
No. of shares beginning of the period | 39,150,472 | 9,349,010 | 28,747,024 | 9,349,010 | 9,349,010 |
No. of shares end of period | 43,050,846 | 9,349,010 | 43,050,846 | 9,349,010 | 28,747,024 |
Average number of shares | 41,100,659 | 9,349,010 | 35,898,935 | 9,349,010 | 19,048,017 |
Highlights Q3 2023
** Due to a later market introduction and rollout in
** Dialogue ensuing with Earkart on revising commercial agreement terms and the remaining part of Audientes receivables, aiming at addressing an acceleration of the Indian market development.
** The Chinese distributor and investor
** Our advanced hearable product, Companion by Audientes, was launched in
** Cost saving initiatives executed earlier in the year around staff cost and external costs in general have started to have a positive impact on EBITDA.
** Agreement with existing bridge-lenders to refinance existing bridge loans with convertible loans of
** An interest-bearing short-term bridge loan of TDKK 780 including accrued interest and a debt of TDKK 50, in total TDKK 830 were converted into equity and new shares issued.
Highlights after Q3 2023
** Completion of a directed issue of
Financial calendar
The Company has updated its financial calendar as follows:
Date | Event |
Q4 / end of year 2023 reporting | |
Annual Report 2023 | |
Q1 2024 reporting | |
Q2 / half-year 2024 reporting | |
Q3 2024 reporting | |
Q4 / end of year 2024 reporting |
For further information, please contact:
Phone: +45 77 34 16 80
Email: st@audientes.com
About Audientes A/S
Audientes A/S is a Danish hearing health company specializing in smart, self-fitting and affordable hearing aids and advanced hearables. Audientes' unique hearing aid solution, Ven(TM) by Audientes, is available for purchase in the Indian and Nepalese markets. Companion by Audientes is an advanced hearable consumer electronics product, marketed in
Audientes' mission is to develop hearing aids and hearables for hearing improvement or enhancement for everyone who needs them globally. Audientes is listed on Spotlight Stock Market Denmark (AUDNTS) and headquartered in
For additional information please refer to the company's websites, www.audientes.com, www.audientes.eu or www.audientes.in.
https://news.cision.com/audientes/r/audientes-a-s--q3-2023-financial-report,c3872940
https://mb.cision.com/Main/21235/3872940/2420716.pdf
https://mb.cision.com/Public/21235/3872940/90f62c45182d441a.pdf
(c) 2023 Cision. All rights reserved., source